Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Homocysteine lowering interventions for preventing cardiovascular events
Cochrane Reviews, 10/19/09
Marti–Carvajal AJ et al. – In this review the authors included eight randomised controlled trials equivalent to 24,210 participants. The authors found no evidence that homocysteine–lowering interventions, in the form of supplements of vitamins B6, B9 or B12 given alone or in combination, at any dosage compared with placebo or standard care, prevents myocardial infarction, stroke, or reduces total mortality in participants at risk or with established cardiovascular disease.
Related Articles
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Annals of Internal Medicine, 10/07/09
Relevance Score: 93%
Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study
Cardiovascular Diabetology, 11/03/09
Relevance Score: 88%
Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges
Drugs & Aging, 10/26/09
Relevance Score: 88%
Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy
Journal of General Internal Medicine, 10/26/09
Relevance Score: 88%
Preventing heart disease in women
Sexuality, Reproduction & Menopause, 10/08/09
Relevance Score: 88%
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationships of BMI to Cardiovascular Risk Factors Differ by Ethnicity
Obesity, 11/20/09
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/20/09
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


